We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LYFT icon
451
Lyft
LYFT
$6.14B
$105K ﹤0.01%
+10,000
New +$111K
2023 Q3
0 quarters
IWM icon
452
CALL
iShares Russell 2000 ETF
IWM
$77.4B
$97.6K ﹤0.01%
40,000
+10,000
+33% +$1.88M
2023 Q2
1 quarter
GDX icon
453
CALL
VanEck Gold Miners ETF
GDX
$26.7B
$97.5K ﹤0.01%
+500,000
New +$14.7M
2023 Q3
0 quarters
CZR icon
454
PUT
Caesars Entertainment
CZR
$6.01B
$93.8K ﹤0.01%
+15,000
New +$797K
2023 Q3
0 quarters
APLS icon
455
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$91.5K ﹤0.01%
+15,000
New +$659K
2023 Q3
0 quarters
XAGEW
456
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$91K ﹤0.01%
+371,250
New +$91.8K
2023 Q3
0 quarters
SVC
457
PUT
Service Properties Trust
SVC
$926M
$80.5K ﹤0.01%
29,260
– –
2021 Q2
9 quarters
XBI icon
458
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
$76.1K ﹤0.01%
+75,000
New +$5.99M
2023 Q3
0 quarters
EXPE icon
459
PUT
Expedia Group
EXPE
$32.9B
$68.2K ﹤0.01%
11,000
– –
2022 Q2
5 quarters
MRTX
460
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$66.9K ﹤0.01%
25,000
– –
2023 Q2
1 quarter
WDC icon
461
PUT
Western Digital
WDC
$149B
$63.4K ﹤0.01%
19,184
– –
2023 Q1
2 quarters
KPTI icon
462
CALL
Karyopharm Therapeutics
KPTI
$13.7M
$60K ﹤0.01%
+20,000
New +$449K
2023 Q3
0 quarters
CONXW icon
463
DELISTED
CONX Corp. Warrant
CONXW
$57.5K ﹤0.01%
460,218
– –
2021 Q1
10 quarters
UAL icon
464
PUT
United Airlines
UAL
$34.9B
$57.3K ﹤0.01%
333,900
– –
2021 Q4
7 quarters
CVIIW icon
465
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$55.9K ﹤0.01%
193,548
– –
2021 Q2
9 quarters
DAL icon
466
PUT
Delta Air Lines
DAL
$54B
$55.5K ﹤0.01%
27,900
– –
2021 Q2
9 quarters
VICI icon
467
PUT
VICI Properties
VICI
$25.2B
$55.4K ﹤0.01%
32,100
– –
2022 Q3
4 quarters
GRTX icon
468
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$52.9K ﹤0.01%
302,506
-268,000
-47% -$333K
2023 Q1
2 quarters
RCUS icon
469
CALL
Arcus Biosciences
RCUS
$3.11B
$52.5K ﹤0.01%
+35,000
New +$703K
2023 Q3
0 quarters
BCYC icon
470
CALL
Bicycle Therapeutics
BCYC
$272M
$52.3K ﹤0.01%
+23,500
New +$537K
2023 Q3
0 quarters
RYTM icon
471
CALL
Rhythm Pharmaceuticals
RYTM
$6.25B
$49.5K ﹤0.01%
+45,000
New +$1.01M
2023 Q3
0 quarters
NAVI icon
472
PUT
Navient
NAVI
$854M
$48.8K ﹤0.01%
37,500
-22,500
-38% -$405K
2021 Q2
9 quarters
ARVN icon
473
CALL
Arvinas
ARVN
$500M
$48K ﹤0.01%
+60,000
New +$1.47M
2023 Q3
0 quarters
BPMC icon
474
CALL
DELISTED
Blueprint Medicines
BPMC
$47.9K ﹤0.01%
+25,000
New +$1.34M
2023 Q3
0 quarters
INCY icon
475
CALL
Incyte
INCY
$22.9B
$47.3K ﹤0.01%
+70,000
New +$4.41M
2023 Q3
0 quarters
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.